Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)
Trial ID or NCT#
Status
Purpose
A research study of a procedure to treating lung cancer with focused radiation called Stereotactic Ablative Radiotherapy (SABR). The purpose of this study is to evaluate the effectiveness of individualizing the dose of radiation used to treat lung tumors with SABR based on tumor-specific factors. While recent research has identified SABR as a promising method to increase local control (LC) of lung cancer, further research has indicated that tumor volume is a prognostic factor, with increased size/volume of tumor being associated with poorer outcomes. This study explores if a volume-adapted strategy for the radiologic exposure (dose) will improve efficacy in larger tumors (ie, \> 10 cc). This is a study of the procedure stereotactic ablative radiotherapy (SABR). It is not a study of a specific drug or device.
Official Title
Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Samantha Wong
650-498-8495
View on ClinicalTrials.gov